C 21 H 19 ClFN 3 O 2 S, monoclinic, P21/n (no. 14), a = 10.1495(4) Å,
Rigaku [1] , Olex2 [2, 3] , SHELX [4] 
Source of material
The title compound was synthesized according to similar procedure described earlier [5] . To a solution of 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (281 mg, 1 mmol) in 10 mL dry DMF under nitrogen atmosphere at 0°C was added (142 mg, 1.1 mmol) DIPEA (diisopropylethylamine). After 20 min, (352 mg, 1.1 mmol) TBTU (2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate) was added and the mixture stirred for 20 min. Thereafter, (0.119 g, 1.1 mmol) of o-phenylenediamine was added and the mixture was stirred for 2 h at 0°C. The resultant mixture was poured on ice and the solid was filtered off. The precipitated solid was filtered, washed with water and dissolved in EtOAc. The organic phase was washed with 1 N HCl aqueous solution, then with a saturated NaHCO 3 aqueous solution, and then H 2 O. The organic layer was dried over MgSO4, and concentrated in vacuo, which was used in the next stage without further purification. The solid was dissolved in 12 mL of dilute acetic acid and refluxed for 2 h. Upon completion, the mixture was poured on ice and the resultant solid was recrystallized from DMSO to produce 300 mg (85% yield) colorless crystals suitable for X-ray structure determination. M.p. = 281-282°C. 
HRMS-ESI (+)
(
Experimental details
Genereal procedures: NMR spectra were recorded with a Bruker Avance III 500 spectrometer. All NMR spectra are reported in parts per million (ppm, d) relative to tetramethylsilane for 1 H and 13 C-NMR spectra, with the residual solvent proton and carbon resonances used as internal standards. Coupling constants (J) are reported in Hertz (Hz), and integrations are reported as number of protons. The following abbreviations are used to described peak patterns: s = singlet, d = doublet, m = multiplet, bs = broad singlet. NMR experiments are given according to the numbering scheme of the molecular structure of the title compound. All H atoms bonded to C atoms were refined as riding, with C-H distances of 0.93 Å (for aromatic rings). X-ray diffraction:
The highest difference electron peak (0.5 e/A 3 ) is located near the sulfur atom, indicating a non-refinable split position for the sufur atom.
Comment
Fluoroquinolone derivatives have been widely investigated as drugs against bacterial infections. Various derivatives prove to be very potent against bacterial and fungal strains and currently in clinical use [6, 7] . In a program aimed to synthesize biologically active compounds, in detail we are searching for a hybridization of the fluroquinolone with benzimidazole [8] [9] [10] [11] . Herein, the carboxylic acid moiety was coupled with o-phenylenediamine and thereafter cyclized to produce the target compound. This title crystal structure consists of the C 19 H14ClFN 3 O molecules, in which all bond lengths are in normal ranges. The asymmetric unit contains both the 3-(1H-benzo[d]imidazol-2-yl)-7-chloro-1-cyclopropyl-6-fluoroquinolin-4(1H)-one and DMSO as a crystallization solvent. The crystal is stabilized via weak CH· · · N and classical NH· · · O hydrogen bonds [N2′· · · O1 = 2.722(6) Å]. The compound except the cyclopropyl is almost planar. The quinolone and the benzimidazole moieties are coplanar due to the Hbonding between the NH and the carbonyl oxygen on C4 of the quinolone part.
